[1]REN Z G,HUO X C,KUMAR J,et al. Review of current large core volume stroke thrombectomy clinical trials:controversies and progress[J/OL]. Stroke:Vascular and Interventional Neurology,2022,2(5):e000330[2023-02-15]. https://doi.org/10.1161/SVIN.121.000330.
[2]YOSHIMURA S,SAKAI N,YAMAGAMI H,et al. Endovascular therapy for acute stroke with a large ischemic region[J]. N Engl J Med,2022,386(14):1303-1313.
[3]HAUSSEN D C,FIEHLER J. By and large,thrombectomy in large core is a palpable reality[J]. Stroke,2022,53(8):2709-2712.
[4]TAO C R,NOGUEIRA R G,ZHU Y Y,et al. Trial of endovascular treatment of acute basilar-artery occlusion[J]. N Engl J Med,2022,387(15):1361-1372.
[5]JOVIN T G,LI C H,WU L F,et al. Trial of thrombectomy 6 to 24 hours after stroke due to basilar-artery occlusion[J]. N Engl J Med,2022,387(15):1373-1384.
[6]SARRAJ A,KLEINIG T J,HASSAN A E,et al. Association of endovascular thrombectomy vs medical management with functional and safety outcomes in patients treated beyond 24 hours of last known well:the SELECT LATE study[J]. JAMA Neurol,2023,80(2):172-182.
[7]MITCHELL P J,YAN B,CHURILOV L,et al. Endovascular thrombectomy versus standard bridging thrombolytic with endovascular thrombectomy within 4·5h of stroke onset:an open-label,blinded-endpoint,randomised non-inferiority trial[J]. Lancet,2022,400(10346):116-125.
[8]FISCHER U,KAESMACHER J,STRBIAN D,et al. Thrombectomy alone versus intravenous alteplase plus thrombectomy in patients with stroke:an open-label,blinded-outcome,randomised non-inferiority trial[J]. Lancet,2022,400(10346):104-115.
[9]GOYAL M,MENON B K,VAN ZWAM W H,et al. Endovascular thrombectomy after large-vessel ischaemic stroke:a meta-analysis of individual patient data from five randomised trials[J]. Lancet,2016,387(10029):1723-1731.
[10]STEEN W,GRAAF R A,CHALOS V,et al. Safety and efficacy of aspirin,unfractionated heparin,both,or neither during endovascular stroke treatment (MR CLEAN-MED):an open-label,multicentre,randomised controlled trial[J]. Lancet,2022,399(10329):1059-1069.
[11]QIU Z M,LI F L,SANG H F,et al. Effect of intravenous tirofiban vs placebo before endovascular thrombectomy on functional outcomes in large vessel occlusion stroke:the RESCUE BT randomized clinical trial[J]. JAMA,2022,328(6):543-553.
[12]RENÚ A,MILLÁN M,SAN ROMÁN L,et al. Effect of intra-arterial alteplase vs placebo following successful thrombectomy on functional outcomes in patients with large vessel occlusion acute ischemic stroke:the CHOICE randomized clinical trial[J]. JAMA,2022,327(9):826-835.
[13]YANG P F,SONG L L,ZHANG Y W,et al. Intensive blood pressure control after endovascular thrombectomy for acute ischaemic stroke (ENCHANTED2/MT):a multicentre,open-label,blinded-endpoint,randomised controlled trial[J]. Lancet,2022,400(10363):1585-1596.
[14]JIA B X,ZHANG X L,MA N,et al. Comparison of drug-eluting stent with bare-metal stent in patients with symptomatic high-grade intracranial atherosclerotic stenosis:a randomized clinical trial[J]. JAMA Neurol,2022,79(2):176-184.
[15]GAO P,WANG T,WANG D M,et al. Effect of stenting plus medical therapy vs medical therapy alone on risk of stroke and death in patients with symptomatic intracranial stenosis:the CASSISS randomized clinical trial[J]. JAMA,2022,328(6):534-542.
[16]REIFF T,ECKSTEIN H H,MANSMANN U,et al. Carotid endarterectomy or stenting or best medical treatment alone for moderate-to-severe asymptomatic carotid artery stenosis:5-year results of a multicentre,randomised controlled trial[J]. Lancet Neurol,2022,21(10):877-888.